ATC Group: V08DA05 Sulfur hexafluoride, phospholipid microspheres

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08DA05 in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08D Ultrasound contrast media
4 V08DA Ultrasound contrast media
5 V08DA05

Active ingredients in V08DA05

Active Ingredient Description
Sulfur hexafluoride

Sulphur hexafluoride is an inert, innocuous gas, poorly soluble in aqueous solutions. Sulphur hexafluoride is for use with ultrasound imaging to enhance the echogenicity of the blood, or of fluids in the urinary tract which results in an improved signal to noise ratio.

Related product monographs

Title Information Source Document Type  
SONOVUE Powder and solvent for dispersion for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicines in this ATC group

Austria (AT)

Brazil (BR)

Canada (CA)

Cyprus (CY)

Estonia (EE)

Finland (FI)

France (FR)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Lithuania (LT)

Poland (PL)

Romania (RO)

Singapore (SG)

Spain (ES)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.